Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

NeuroPace Raises FY2025 Sales Guidance from $94.000M-$98.000M to $97.000M-$98.000M vs $95.674M Est

Author: Benzinga Newsdesk | November 04, 2025 04:09pm
NeuroPace (NASDAQ:NPCE) raises FY2025 sales outlook from $94.000 million-$98.000 million to $97.000 million-$98.000 million vs $95.674 million estimate.

Posted In: NPCE


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist